Lynn Patel
Family · Jacksonville, FLNPI 1952649642
Payments from drug & device makers
Across 53 payments — averaging $21.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$101
- Bayer$88
- Sequel Med Tech, LLC$82
- Antares Pharma, Inc.$71
- Novo Nordisk$57
- Lilly USA, LLC$56
- plus $673 from 22 others
What the payments were for
- Food & beverage$1,128100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $101 |
| Bayer | 4 | $88 |
| Sequel Med Tech, LLC | 4 | $82 |
| Antares Pharma, Inc. | 3 | $71 |
| Novo Nordisk | 3 | $57 |
| Lilly USA, LLC | 3 | $56 |
| Tandem Diabetes Care, Inc. | 3 | $54 |
| Dexcom, Inc. | 3 | $51 |
| Abbott | 2 | $47 |
| Cochlear Americas | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Stryker | 2 | $39 |
| Boehringer Ingelheim | 2 | $36 |
| Recordati_rare_diseases_inc. | 2 | $33 |
| Sanofi | 1 | $33 |
| Amgen | 2 | $31 |
| Insulet Corporation | 1 | $30 |
| Rhythm Pharmaceuticals, Inc. | 1 | $30 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Optinose US, Inc. | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Chiesi USA, Inc. | 1 | $20 |
| Tolmar, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
| Pulse Biosciences, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
How this compares
$1,128 in reported general payments places this provider in the 70th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinolone Acetonide Oil | 100 | $5,019 |
| Fluticasone Propionate | 244 | $3,636 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 27 | $3,062 |
| Ipratropium Bromide | 83 | $2,362 |
| Azelastine Hcl | 38 | $1,172 |
| Omeprazole | 85 | $651 |
| Dexamethasone Sodium Phosphate | 16 | $455 |
| Levocetirizine Dihydrochloride | 26 | $341 |
| Mupirocin | 43 | $323 |
| Ofloxacin | 12 | $252 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $207 |
| Triamcinolone Acetonide | 23 | $206 |
| Famotidine | 20 | $154 |
| Meclizine Hcl | 18 | $44 |
Paid to pharmacies, not to this prescriber.
Other family in Jacksonville
- Leighanne MeadeJacksonville$98K
- Jori TaylorJacksonville$48K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.